← Oncology Approval Tracker

FDA DECISION ·

Romidepsin injection

romidepsin · Amneal EU

First generic approvalFirst genericCutaneous T-cell lymphoma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

First generic of the reference romidepsin injection for adults with cutaneous T-cell lymphoma after at least one prior systemic therapy.

LAMPGEN ANALYSIS

Why it matters

This approval concerns the listed injectable presentation for an established later-line use in cutaneous T-cell lymphoma.

What research teams should watch

Verify the selected formulation, preparation and sourcing before updating a pharmacy workflow. Track prior systemic therapy in clinical documentation.

PRIMARY RECORDS

Sources